Wisconsin Alumni Research Foundation

Therapeutics & Vaccines
Therapeutics Vaccines
Influenza M2 Protein Mutant Viruses As Influenza Live Attenuated Vaccines
WARF: P07509US

Inventors: Yoshihiro Kawaoka, Tokiko Watanabe

The Invention
A method to prepare recombinant influenza viruses comprising a mutant M2 protein which has a deletion of two or more residues in the cytoplasmic tail and is attenuated in vivo, is provided, as well the resulting virus and vaccines with the virus.
Additional Information
Related Intellectual Property
For current licensing status, please contact Jennifer Gottwald at [javascript protected email address] or 608-960-9854